Market Access Transformation specializes in developing cutting edge technologies that enable the healthcare community to gather and exchange insight that assess the real-world potential of their products.

About us - features.png

Global Payer Insight On Demand

VALUE STRATEGY INSIGHT

Target Product Profile Assessment (TPP)
validate clinical assumptions and access opportunities with payers.

Payer Evidence Planning 
test the strength of your evidence generation plan to meet payers needs and expectations.

Value Proposition and Messaging Testing
test your value proposition and corresponding messaging at various stages to ensure relevance and high-impact with payers.

Value Communication Planning
vet and prioritize key value messages to help identify how your product is most impactful to different payer types through RPR.

BY DEVELOPMENT STAGE

Early Stage Development
understand treatment landscape, unmet need, shape TPP, make go/no-go decisions, etc.

Phase II
support pricing & reimbursement objectives, economic modeling, vet the design of clinical trials parameters, and more by getting payer feedback.

Phase III
evidence generation planning, update pricing & reimbursement strategy directly with payers.

Late Stage / Launch
validate your product’s clinical and commercial strategies with payers across different markets.

New Indication
test the impact of new indication and the overall value of your product by obtaining feedback from payers.

SITUATIONAL INSIGHT

HEOR-related
validate your economic modeling framework and evidence generation strategy.

Emerging Markets
understand barriers to access, key decisions and success factors by engaging directly with payers in emerging markets.

Medical Device | Diagnostics | Vaccines
understand product value evaluation and funding pathways strategy for your product by assessing payer insight.

Pricing, Reimbursement and Contracting Strategy
test your early and late price planning, indication-based pricing scenarios, willingness to pay, global pricing strategy, reimbursement objectives and scenario planning, launch and LoE price optimization, contracting strategy and more with RPR™.

LEADERSHIP

BAIJU AURORA     CEO & Co-Founder

BAIJU AURORA
CEO & Co-Founder

PAUL HOWARD     Board Vice Chairman & Co-Founder

PAUL HOWARD
Board Vice Chairman & Co-Founder

DR. KULDEEP SINGH   VP & Head of Global Market Access Operations

DR. KULDEEP SINGH
VP & Head of Global Market Access Operations

MARTIN HANNON    VP & Head of Technology

MARTIN HANNON
VP & Head of Technology


SENIOR MANAGEMENT

ALEX PATTIS   Director of Global Commercial Development

ALEX PATTIS
Director of Global Commercial Development

LOES VAN ERP     Director of Global Commercial Development

LOES VAN ERP
Director of Global Commercial Development

NICK DEJESUS   Director of Global Commercial Development

NICK DEJESUS
Director of Global Commercial Development

HEBE BERGER      Associate Director of Corporate Marketing

HEBE BERGER
Associate Director of Corporate Marketing

GENEVIEVE CLAPTON, PhD   Associate Director of Market Access Operations

GENEVIEVE CLAPTON, PhD
Associate Director of Market Access Operations

DOMINIC JONES-PHILLIPS, PhD   Sr. Consultant, Client Engagement Manager

DOMINIC JONES-PHILLIPS, PhD
Sr. Consultant, Client Engagement Manager

ALEX GRAHAM   Sr. Consultant, Client Engagement Manager

ALEX GRAHAM
Sr. Consultant, Client Engagement Manager

MEGHANA NARJAL, MD   Consultant, Client Engagement Manager

MEGHANA NARJAL, MD
Consultant, Client Engagement Manager

 
STEFANIA ZACCARI   Senior Global Payer Relationship Manager

STEFANIA ZACCARI
Senior Global Payer Relationship Manager

ANGIE GREENLEES   Global Payer Relationship Manager

ANGIE GREENLEES
Global Payer Relationship Manager